Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2013 May 9;139(2):515–527. doi: 10.1007/s10549-013-2477-2

Table 3.

Social network members and quality of life outcomes

N Fact-B** 95% CI Fact-G 95% CI TOI-PFB 95% CI
Married*
 Yes 1,846 Ref Ref Ref
 No 1,348 −4.96 (−6.41, −3.52) −3.90 (−5.04, −2.77) −1.77 (−2.85, −0.69)
 p-value <0.001 <0.001 0.001
Close friends and relatives
 >15 812 Ref Ref Ref
 10-15 1,120 −2.46 (−4.09, −0.83) −1.75 (−3.03, −0.47) −1.26 (−2.48, −0.03)
 6-9 664 −6.20 (−8.06, −4.34) −4.94 (−6.41, −3.48) −3.32 (−4.72, −1.92)
 0-5 598 −10.54 (−12.48, −8.60) −8.86 (−10.39, −7.34) −5.29 (−6.75, −3.83)
 p-value, continuous <0.001 <0.001 <0.001
Any church participation
 Yes 2,230 Ref Ref Ref
 No 964 −1.78 (−3.20, −0.37) −1.42 (−2.54, −0.30) −0.90 (−1.96, 0.15)
 p-value 0.01 0.01 0.09
Any volunteering
 Yes 825 Ref Ref Ref
 No 2,369 −1.90 (−3.39, −0.42) −1.43 (−2.60, −0.26) −1.29 (−2.40, −0.19)
 p-value 0.01 0.02 0.02
*

Multivariate-adjusted models adjusted for age (continuous), race/ethnicity (White (ref), African-American, Hispanic, Asian, other), education (<HS, HS, <college, college degree or greater), income (<$25K, $25-<$70K, $70K+(ref)), stage (I (ref), II, III, IV), estrogen receptor status (positive, negative (ref)), nodal status (positive, negative (ref)), surgery type (mastectomy (ref), lumpectomy, other), chemotherapy (yes, no (ref)), hormonal treatment (yes, no (ref)), radiation (yes, no (ref)), menopausal status (postmenopausal, premenopausal (ref)), parity (0, 1-2, 3 or more), comorbidity (any comorbidity defined by Charlson index, no (ref)), body mass index (BMI<25 (ref), 25-<30, 30+ kg/m2), smoking (never (ref), past, current), physical activity (quartiles, Q1=ref).

**

FACT-B=Functional Assessment Cancer Therapy-Breast; FACT-G=Functional Assessment Cancer Therapy-General; TOI-PFB=Trial Outcome Index-Physical/Functional/Breast